Related Experiment Videos
[Harmonization of testing drugs for bioequivalence: problems and possible solutions]
V P Zherdev1, G B Kolyvanov, A A Litvin
1Zakusov Institute of Pharmacology, Russian Academy of Medical Sciences, Baltiiskaya ul. 8, Moscow, 125315 Russia.
Eksperimental'Naia I Klinicheskaia Farmakologiia
|September 10, 2003
Summary
Testing generic drugs for bioequivalence presents challenges, especially with complex formulations, genetic metabolism variations, and local administration. Methodological guidelines need improvement to address these issues for accurate drug evaluation.
Area of Science:
- Pharmacokinetics and Drug Metabolism
- Pharmaceutical Sciences
- Regulatory Science
Context:
- Challenges in bioequivalence testing for generic drugs.
- Gaps in current domestic methodological recommendations.
- Need for updated guidelines in pharmaceutical development.
Purpose:
- Discuss unresolved issues in bioequivalence testing.
- Highlight special cases requiring specific analytical approaches.
- Address limitations in current regulatory frameworks.
Summary:
- Examines difficulties in bioequivalence assessment for generics.
- Covers complex scenarios: variable concentrations, endogenous substances, polymorphic metabolism, long half-lives, and local delivery.
- Identifies insufficient analytical sensitivity and ethical considerations.
Impact:
- Aims to improve the accuracy and reliability of generic drug testing.
- Promotes the development of more robust methodological recommendations.
- Ensures the safety and efficacy of generic medications for patients.